Showing results for: T Cell Therapy Manufacturers, Suppliers & Companies
-
Manufacturerbased in Philadelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Adaptimmune - Model ADP-A2M4 (MAGE-A4) - Spear T-Cell Therapy
Our ADP-A2M4 (MAGE-A4) SPEAR T-cell therapy is directed to a member of the MAGE family of cancer testis antigen expressed in a number of solid tumor cell types. The MAGE- A4 antigen ...
CONTACT SUPPLIER -
Manufacturerbased in Waltham, MASSACHUSETTS (USA)
AlloVir is the global leader in developing VST immunotherapies. We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. AlloVir is a leading late ...
Model Posoleucel (Viralym-M, ALVR105) - Multi-Virus Specific T cell Therapy (VST)
Posoleucel targets five devastating viral pathogens: BK virus (BKV), Cytomegalovirus (CMV), Adenovirus (AdV), Epstein-Barr Virus (EBV), and Human Herpesvirus 6 (HHV-6), and has the potential to transform care for transplant recipients. ...
CONTACT SUPPLIER -
Manufacturerbased in Aberdeen, CHINA
Over the last 10 years, Creative Biolabs has become a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Creative Biolabs was founded by ...
γδ T Cell Therapy Development Services
As the main component of the immune system, T cells protect the body from infections and tumors by a diversity of bio-functions, including recognition and presentation specific antigens, directly killing target ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...
Adaptive - Model TruTCR - Drug Discovery T-Cell Therapy for Cellular Therapy
We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our end-to-end capabilities for the development of cellular ...
CONTACT SUPPLIER -
Manufacturerbased in NEW JERSEY (USA)
Tevogen Bio is driven by a team of distinguished scientists and experienced biopharmaceutical leaders who have developed and commercialized multiple franchises. In collaboration with key strategic partners, the company moved its lead product from ...
Tevogen - Allogeneic CD8+ T Cell Therapies
Innovative Science in Virology, Oncology, and Neurology; Allogeneic CD8+ T cell therapies from a single donor to treat thousands for the first ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
CAR T-Cell Therapy
CAR T-cell therapy is the engineering of a patient’s T cells, a type of white blood cell. A small portion of these cells are ...
CONTACT SUPPLIER -
Technologybased in Berkeley, CALIFORNIA (USA)
Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell ...
CAR-T - Cell Therapies for Hematologic Cancers
CAR-T cell therapies are a class of treatments in which T cells are modified to express chimeric antigen receptors (CARs). CARs are engineered molecules that, ...
CONTACT SUPPLIER -
Manufacturerbased in Duisburg, GERMANY
Genekam Biotechnology AG was found in 1999. It started offering DNA-Tests in 2001. From 2004, it started development of PCR kits while exporting to 5 countries, today (2015) it exports to 70 countries in the world. Genekam covers different targets ...
T-cell Immunotherapy Solution - Car T-cell Therapy Services
There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT819 - CAR T-cell Therapy
CAR T-cell therapy has recently emerged as a revolutionary and potentially curative therapy for patients with certain hematologic malignancies, including refractory cancers. In ...
CONTACT SUPPLIER -
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Receptor Therapy T Cell
T cell engineering with TCRs is a growing area of immuno-oncology with recent breakthroughs in clinical settings. The T-Cure approach involves identifying and isolating a high avidity TCR which ...
CONTACT SUPPLIER -
Technologybased in Carlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Chimeric - Model CHM 1101 (CLTX CAR T) - T Cell Derived Autologous Therapies
CHM 1101 (CLTX CAR T) is an optimized first-in-class CAR T cell therapy that uniquely utilizes Chlorotoxin (CLTX), a 36-amino acid peptide derived from deathstalker scorpion venom ...
CONTACT SUPPLIER -
Manufacturerbased in Philadelphia, PENNSYLVANIA (USA)
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T ...
-
Manufacturerbased in Holytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
Gamma Delta T Cells
Our therapies are focused on leveraging the inherent biological capabilities of gamma delta T cells (GDT cells) together with an integrated cell engineering ...
CONTACT SUPPLIER -
Manufacturerbased in Carlsbad, CALIFORNIA (USA)
TargaZyme is a clinical-stage biotechnology company based in San Diego, CA and focused on the research and development of disruptive and novel, off-the-shelf T-Cell products that are aimed at improving the efficacy of T-cell therapies by delivering ...
Tumor Infiltrating Lymphocyte (TIL) Therapies
TILs are part of the body’s natural response to cancer:The cells of the immune system perform immunosurveillance while circulating throughout the bodyAs part of the normal immune response, TIL migrate to the tumor site through ...
CONTACT SUPPLIER -
Manufacturerbased in Mont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
Manufacturing Science Services
In-house production facility underpins broad CAR T pipeline. Over the past decade, Celyad Oncology has established expertise in Good Manufacturing Practice (GMP) grade cell therapy manufacturing at ...
CONTACT SUPPLIER -
Technologybased in São Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy
The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is ...
CONTACT SUPPLIER -
Manufacturerbased in New York, NEW YORK (USA)
Aurora Biopharma is founded on a single mission to revolutionize the treatment of cancer, by using the human body’s immune system. Aurora is developing state-of-the-art cancer immunotherapy, a form of adoptive cell transfer called Chimeric Antigen ...
Aurora Biopharma - Innovative Cancer Immunotherapy Technolgoy
revolutionary CAR T Cell Therapy change a cancer patient’s own weak T cells into “bionic” killing machines —a highly targeted army that can ...
CONTACT SUPPLIER -
Manufacturerbased in Menlo Park, CALIFORNIA (USA)
Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and ...
Gamma delta T cells
Gamma delta T cells represent a new generation of universal cell therapy. The current engineered autologous alpha beta T cell products have shown ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
-
Manufacturerbased in New York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
DeltEx DRI - Model INB-200 - Autologous Gamma-Delta T Cell Product
INB-200, our DeltEx DRI, is a genetically modified autologous gamma-delta T cell product candidate for the treatment of solid tumors. This is the first genetically engineered gamma-delta T ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you